Virtu Financial »

Tscan Therapeutics shares owned by Virtu Financial

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Virtu Financial from 13F filings

Historical chart of Virtu Financial investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Virtu Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Virtu Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $107k 18k 5.81

More positions owned by Virtu Financial

Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Select Sector Spdr Tr Technology (XLK)
Meta Platforms Cl A (META)
Direxion Shs Etf Tr Drx S P500bull (SPXL)
Direxion Shs Etf Tr 20yr Tres Bear (TMV)
Vanguard Index Fds S P 500 Etf Shs (VOO)
Select Sector Spdr Tr Financial (XLF)
Synopsys (SNPS)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Altria (MO)
Hess (HES)
Pfizer (PFE)
News Corp Cl A (NWSA)
Invesco Currencyshares Cdn D CDN DLR SHS (FXC)

View all positions for Virtu Financial

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
Deer Management
Alphabet
Simplify Asset Management
Standard Life Aberdeen
Stifel Financial
Marshall Wace
Millennium Management
NewEdge Wealth
Jane Street

View all funds holding Tscan Therapeutics